Electrode-Based Neuromodulation for Refractory Painful Diabetic Peripheral Neuropathy: A Narrative Review of Current Evidence and Clinical Integration
Anesthesiology and Pain Medicine · 31.08.2026 · 16 (4)
DOI: 10.5812/aapm-175036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anesthesiology and Pain Medicine, online erschienen am 31.08.2026. Verfasst von Karim Hemati und 4 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context
Painful diabetic peripheral neuropathy (PDPN) is a complex, progressive complication characterized by small-fiber degeneration, microvascular insufficiency, metabolic stress, and maladaptive central sensitization. First-line medications are generally only partially effective and frequently provide incomplete or insufficiently durable relief, underscoring the importance of mechanism-based interventions. Evidence Acquisition: This narrative review was based on searches of PubMed/MEDLINE, Embase, Scopus, and the Cochrane Library from database inception through 2026, with priority given to English-language studies involving human subjects. The evidence was narratively synthesized and appraised by experts rather than systematically pooled, and no meta-analysis was performed.
Results
Neuromodulation directly modulates dysfunctional nociceptive circuits through approaches such as peripheral nerve stimulation (PNS), dorsal root ganglion stimulation (DRGS), and spinal cord stimulation (SCS). These emerging treatments may also provide microvascular and neuroimmune benefits. High-frequency and burst SCS provide nonparesthetic analgesia through mechanisms more congruent with endogenous pain-modulatory physiology, whereas closed-loop SCS based on evoked compound action potentials (ECAPs) enables real-time, stable engagement of neural tissue. Recent improvements in wireless platforms, miniaturized micro-electrode systems, and regenerative stimulation have increased therapeutic applications and decreased procedural burden while improving neural selectivity. Neuromodulation is progressing toward personalized, adaptive treatment through data-driven optimization of stimulation parameters and phenotype-specific programming, facilitated by artificial intelligence (AI). Biomarker-guided patient selection using quantitative sensory testing, intra-epidermal nerve fiber density, electrophysiologic measures, and advanced imaging is proposed as a framework for aligning therapeutic modality with disease phenotype. However, no biomarker has yet been validated to predict response to neuromodulation in PDPN, and this stratification remains hypothesis-generating and has not been prospectively validated.
Conclusions
Neuromodulation is emerging as a mechanism-targeted and increasingly individualized approach for refractory PDPN that can provide sustained pain relief and functional benefits when other treatments have been ineffective. Preliminary evidence also suggests possible disease-modifying properties, although these require confirmation in PDPN-specific, long-term comparative trials.
Zitieren
APA
Hemati, K., Mohseni, M., Alebouyeh, M., Azizi, A., & Hafshejani, F. A. (2026). Electrode-Based Neuromodulation for Refractory Painful Diabetic Peripheral Neuropathy: A Narrative Review of Current Evidence and Clinical Integration. Anesthesiology and Pain Medicine, 16(4). https://doi.org/10.5812/aapm-175036
Vancouver
Hemati K, Mohseni M, Alebouyeh M, Azizi A, Hafshejani FA. Electrode-Based Neuromodulation for Refractory Painful Diabetic Peripheral Neuropathy: A Narrative Review of Current Evidence and Clinical Integration. Anesthesiology and Pain Medicine. 2026;16(4). doi:10.5812/aapm-175036
BibTeX
@article{Hemati2026,
author = {Hemati, Karim and Mohseni, Masood and Alebouyeh, Mahmood-Reza and Azizi, Ali and Hafshejani, Fatemeh Ahmadi},
title = {Electrode-Based Neuromodulation for Refractory Painful Diabetic Peripheral Neuropathy: A Narrative Review of Current Evidence and Clinical Integration},
journal = {Anesthesiology and Pain Medicine},
year = {2026},
volume = {16},
number = {4},
doi = {10.5812/aapm-175036}
}
EUVIMED